What is ABECMA? ABECMA (idecabtagene vicleucel) is a prescription medicine for the treatment of multiple myeloma in patients who have received at least four kinds of treatment regimens that have not worked or have stopped working. ABECMA is a medicine made from your own white blood cells; the cells are genetically modified to recognize and attack your multiple myeloma cells.
This website is best viewed using the horizontal display on your tablet device.
This website is best viewed using the vertical display on your mobile device.
At the specialized manufacturing laboratory:
Your healthcare provider may also recommend other treatments to manage your multiple myeloma while your ABECMA is created and multiplied.
CARs=chimeric antigen receptors.
*The treatment process includes blood collection, CAR T cell creation, administration, and adverse event monitoring.
†There is a risk of manufacturing failure. In the ABECMA clinical trial, 2 out of 135 patients were impacted. Speak to your doctor for more information.
‡Your dose of ABECMA may be given in one or more infusion bags.